Back

Comparative analysis of atrial fibrillation risk in patients with vascular ehlers-danlos syndrome vs. marfan's syndrome

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Atrial fibrillation in complex patients Genetic Causes ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luke Dreher

Mayo Clinic, Scottsdale (United States of America)

7 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Tezuka (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Assistant Professor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Ms A. Lizancos Castro (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Associate Professor M. Casella (Ancona, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Atrial fibrillation in complex patients

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Ventricular tachycardia in patients with vascular ehlers-danlos syndrome vs. Marfan's syndrome: an international database analysis
1 September 2025
thumbnail
Congress Presentation
The risk of incident atrial fibrillation in patients with inflammatory arthritis: a hierarchical clustering approach from the Hong Kong Hospital Authority Data Collaboration Laboratory (HADCL)
30 August 2025
thumbnail
Congress Presentation
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
28 August 2026
thumbnail
Congress Presentation
Prevalence and cardiovascular implications of mitral valve prolapse in marfan syndrome: insights from a multicenter observational study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources